Pharmacotherapy for Cushing disease: a recent Australian experience with osilodrostat

Prishila Fookeerah, Mark McLean

Research output: Contribution to journalArticlepeer-review

Abstract

Cushing disease (CD), hypercortisolism due to an adrenocorticotropic hormone (ACTH)–secreting corticotroph tumour, is a rare condition associated with significant morbidity and mortality. The estimated incidence is 1.6 cases per million population; about 40 cases per year in Australia
Original languageEnglish
Pages (from-to)451-452
Number of pages2
JournalInternal Medicine Journal
Volume53
Issue number3
DOIs
Publication statusPublished - Mar 2023

Fingerprint

Dive into the research topics of 'Pharmacotherapy for Cushing disease: a recent Australian experience with osilodrostat'. Together they form a unique fingerprint.

Cite this